Sanofi Genzyme Grant

"The objective of the Type 2 Innovation Grant is to support independent, novel and innovative research projects investigating Type 2 immune-mediated diseases, such as atopic dermatitis and asthma.

Qualifying research grant applicants will be requested to select between two disease areas, Dermatology or Respiratory. The applications will then be evaluated against predefined criteria by two independent panels of international experts, one per disease area. The four most relevant research projects in each category will be selected and will each receive a research grant up to EUR 80,000 (subject to fulfillment of the conditions specified under point 8 below). In total 8 projects will be selected to receive a research grant.

You have until the 31st of May 2019 to submit your application."

Established Researcher, Post Doctoral Researcher
Research project
Leena Sivula,, 0408055116

Tämä kansio on tyhjä.